4,4,5,5-Tetramethyl-2-(2,4,6-trifluorophenyl)-1,3,2-dioxaborolane, 97%, 5g

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, 98%, 25g

HPLC column NUCLEODUR® 100-3 C8 ec, 250 mm, 4 mm, 1 Piece(s)

2,4,6-Trihydroxybenzaldehyde>98.0%(HPLC)5g

1-butyl-5-(chloromethyl)-2-methanesulfonyl-1H-imidazole, 95.0%, 10g

3,4,7,8-Tetramethyl-1,10-phenanthroline, 95.0%, 100g

(R)-(-)-3-Aminopiperidine Dihydrochloride>97.0%(T)1g

Methyl oxindole-6-carboxylate, 95.0%, 500g

tert-Butyl (3R,5S)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate, 95.0%, 5g

3-Amino-5-fluoropyridine, 98.0%, 10g

3-(tert-Butylthio)pyridin-2-amine, 95.0%, 100mg

tert-Butyl 4-(2-chlorobenzylamino)piperidine-1-carboxylate, 95.0%, 1g

4,6-Dichloronicotinic acid methyl ester, 98.0%, 10g